TetraPhase Pharmaceuticals to Present at the Annual UBS Global Healthcare Conference

Published: May 17, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH), a clinical-stage biopharmaceutical company developing a portfolio of potent new antibiotics designed to be effective against dangerous, drug-resistant bacteria (including multidrug-resistant (MDR) gram-negative pathogens), today announced that Tetraphase Senior Vice President & Chief Financial Officer David Lubner will present at the annual UBS Global Healthcare Conference on Wednesday, May 22, at 9:00 AM a.m. Eastern Time. The conference will take place at The Sheraton Hotel in New York City.

Help employers find you! Check out all the jobs and post your resume.

Back to news